Monospin Tablet 80 mg (Telmisartan)

Adult dose

As Telmisartan, administer 40 mg once daily orally with water, regardless of meals. For some patients, 20 mg once daily may be effective, and if necessary, the dose may be increased up to 80 mg once daily. The maximum blood pressure-lowering effect is usually observed 4 to 8 weeks after treatment initiation. For reducing cardiovascular disease risk, take 80 mg once daily orally with water.

This medication can cause severe harm to the fetus and newborn, particularly during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to this medication or its ingredients, pregnant or nursing women, patients with severe liver impairment, patients with hereditary angioedema, or patients with diabetes or severe kidney impairment. Caution should be exercised when administering to elderly patients or those with hyperkalemia, liver impairment, or cardiovascular diseases, as there is a risk of myocardial infarction or stroke if blood pressure drops too low. While taking this medication, various adverse reactions such as infections, blood abnormalities, hyperkalemia, hypoglycemia, kidney function deterioration, liver function abnormalities, and allergic reactions may occur, so any abnormal symptoms should be reported to medical personnel immediately. Particularly serious side effects such as angioedema, shock, syncope, interstitial pneumonia, or rhabdomyolysis may occur, so symptoms should be closely monitored. In patients with impaired kidney function, serum potassium and creatinine levels should be regularly monitored, and caution is necessary as hypotension may occur in states of reduced blood volume or sodium. Additionally, interactions may occur when this medication is used in conjunction with other antihypertensive medications, certain diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so it is essential to consult a doctor or pharmacist. Women who are pregnant or nursing are advised not to take this medication; if it must be taken, breastfeeding should be stopped. Its safety and efficacy in children under 18 years have not been established, so it is not recommended. In case of overdose, symptoms such as hypotension, dizziness, acute renal failure, etc., may occur, requiring immediate medical attention and frequent monitoring of blood pressure and electrolyte levels. This medication should be kept out of the reach of children, maintained in a sealed state until use, and not transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, shortness of breath, cold sweat, paleness, severe allergic reaction, severe rash with high fever, blisters, skin peeling, mucosal pain in mouth/eyes, severe skin adverse reactions, difficulty breathing or shortness of breath, asthma attack, respiratory issues accompanied by cough and fever, jaundice (yellowing of skin or eyes), excessive fatigue, liver dysfunction (jaundice), sudden and

Mild side effects

• Upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained at room temperature between 1 degree to 30 degrees. This way, the effectiveness of the medication can be safely preserved.

Appearance

White oval tablet

Package unit

30 tablets/box [10 tablets/PTP×3], 30 tablets/bottle